Medical costs, hospitalizations, and length of stay associated with discontinuations in cycled oral antineoplastics among Medicare-eligible oncology patients
Summary
MarketScan Medicare study sample demonstrated that medication adherence (fewer gaps in medicaton coverage) among patients on cycled oral antineoplastics can lead to lower medical costs, fewer hospitlization events and shorter lenght of stay as compared to lower adherence levels.
DATE PUBLISHED
May 07, 2023
FORMAT
Poster
AUTHORS
Francis Staskon, Edward A. Witt, Laly Havern